Delphi Consensus Among International Experts on the Diagnosis, Management, and Surveillance for Lentigo Maligna

dc.contributor.authorLongo, Caterina
dc.contributor.authorNavarrete-Dechent, Cristian
dc.contributor.authorTschandl, Philipp
dc.contributor.authorApalla, Zoe
dc.contributor.authorArgenziano, Giuseppe
dc.contributor.authorBraun, Ralph P.
dc.contributor.authorBataille, Veronique
dc.contributor.authorCabo, Horacio
dc.contributor.authorHoffmann-Wellhenhof, Rainer
dc.contributor.authorForsea, Ana Maria
dc.contributor.authorGarbe, Claus
dc.contributor.authorGuitera, Pascale
dc.contributor.authorRaimond, Karls
dc.contributor.authorMarghoob, Ashfaq A.
dc.contributor.authorMalvehy, Josep
dc.contributor.authorDel Marmol, Veronique
dc.contributor.authorMoreno, David
dc.contributor.authorNehal, Kishwer S.
dc.contributor.authorNagore, Eduardo
dc.contributor.authorPaoli, John
dc.contributor.authorPellacani, Giovanni
dc.contributor.authorPeris, Ketty
dc.contributor.authorPuig, Susana
dc.contributor.authorSoyer, H. Peter
dc.contributor.authorSwetter, Susan
dc.contributor.authorStratigos, Alexander
dc.contributor.authorStolz, Wilhelm
dc.contributor.authorThomas, Luc
dc.contributor.authorTiodorovic, Danica
dc.contributor.authorZalaudek, Iris
dc.contributor.authorKittler, Harald
dc.contributor.authorLallas, Aimilios
dc.date.accessioned2025-01-20T17:14:21Z
dc.date.available2025-01-20T17:14:21Z
dc.date.issued2023
dc.description.abstractIntroduction: Melanoma of the lentigo maligna (LM) type is challenging. There is lack of consensus on the optimal diagnosis, treatment, and follow-up.
dc.description.abstractObjectives: To obtain general consensus on the diagnosis, treatment, and follow-up for LM.
dc.description.abstractMethods: A modified Delphi method was used. The invited participants were either members of the International Dermoscopy Society, academic experts, or authors of published articles relating to skin cancer and melanoma. Participants were required to respond across three rounds using a 4-point Likert scale). Consensus was defined as >75% of participants agreeing/strongly agreeing or disagreeing/strongly disagreeing.
dc.description.abstractResults: Of the 31 experts invited to participate in this Delphi study, 29 participants completed Round 1 (89.9% response rate), 25/31 completed Round 2 (77.5% response rate), and 25/31 completed Round 3 (77.5% response rate). Experts agreed that LM diagnosis should be based on a clinical and dermatoscopic approach (92%) followed by a biopsy. The most appropriate primary treatment of LM was deemed to be margin-controlled surgery (83.3%), although non-surgical modalities, especially imiquimod, were commonly used either as alternative off-label primary treatment in selected patients or as adjuvant therapy following surgery; 62% participants responded life-long clinical follow-up was needed for LM.
dc.description.abstractConclusions: Clinical and histological diagnosis of LM is challenging and should be based on macroscopic, dermatoscopic, and RCM examination followed by a biopsy. Different treatment modalities and follow-up should be carefully discussed with the patient.
dc.fuente.origenWOS
dc.identifier.doi10.5826/dpc.1303a244
dc.identifier.issn2160-9381
dc.identifier.urihttps://doi.org/10.5826/dpc.1303a244
dc.identifier.urihttps://repositorio.uc.cl/handle/11534/91289
dc.identifier.wosidWOS:001074574200031
dc.issue.numero3
dc.language.isoen
dc.revistaDermatology practical & conceptual
dc.rightsacceso restringido
dc.subjectmelanoma
dc.subjectlentigo maligna
dc.subjectDelphi
dc.subjectdiagnosis
dc.subjectmanagement
dc.subject.ods03 Good Health and Well-being
dc.subject.odspa03 Salud y bienestar
dc.titleDelphi Consensus Among International Experts on the Diagnosis, Management, and Surveillance for Lentigo Maligna
dc.typeartículo
dc.volumen13
sipa.indexWOS
sipa.trazabilidadWOS;2025-01-12
Files